{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:06:14Z","timestamp":1784559974511,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170412"],"award-info":[{"award-number":["82170412"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tongji Hospital Affiliated to Tongji University funds for scientific research","award":["RCQD2405"],"award-info":[{"award-number":["RCQD2405"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute liver injury (ALI) can rapidly progress to life-threatening acute liver failure. Liver transplantation remains the only definitive treatment, despite critical donor shortages. Macrophage-based therapies have shown promise in ALI but face challenges related to subset imprecision and limited humanized validation. VSIG4 is generally considered a marker of Kupffer cells; however, it is also expressed in monocyte-derived macrophages (MoMFs), and its role remains unclear during ALI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      By integrating single-cell RNA sequencing (scRNA-seq) data from human and mouse liver tissues with clinical ALI tissue samples, we elucidated the dynamic changes in VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      macrophages (VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      M\u03c6) within the liver. We developed a reversible immunomagnetic nanoparticle system for the non-destructive isolation of viable VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      M\u03c6. The therapeutic efficacy and potential mechanisms of VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      M\u03c6 were evaluated through tissue and molecular-level analyses in an acetaminophen (APAP)-induced ALI mouse model, as well as in a newly established vascularized human liver organoid ALI and monocyte chemotaxis model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      scRNA-seq revealed a previously underrecognized subpopulation of VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      MoMFs, which increases following ALI, while the number of resident VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      Kupffer cells decreases significantly. Clinical ALI tissue samples also confirmed the presence of CCR2\n                      <jats:sup>+<\/jats:sup>\n                      VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      cells in the livers of patients with ALI. In the APAP-induced ALI animal model, adoptive transfer of isolated VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      MoMFs dramatically decreased serum alanine transaminase, hepatic necrosis, and apoptosis while increasing anti-inflammatory cytokines. In contrast, adoptive transfer of unselected BMDM failed to improve liver injury and instead exacerbated certain pro-inflammatory responses, including elevated TNF-\u03b1 and reduced CD206 expression. Mechanistically, VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      MoMFs prevented inflammatory amplification by suppressing NF-\u03baB-dependent CCL2 transcription, thereby disrupting the CCL2-CCR2 chemotactic axis and reducing pro-inflammatory CCR2\n                      <jats:sup>+<\/jats:sup>\n                      monocyte and macrophage recruitment. We further developed vascularized human liver organoids and APAP-induced hepatocyte injury and monocyte chemotaxis, finding that the chemotaxis-interrupting mechanism was fully recapitulated in the human liver organoid ALI model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This study identifies VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      MoMFs as a therapeutically viable subset for ALI, with clear superiority over unselected BMDM. By blocking the CCL2-CCR2 inflammatory amplification loop, these cells attenuate liver injury in both mouse and humanized models. These consistent findings provide robust preclinical evidence to support the advancement of VSIG4\n                      <jats:sup>+<\/jats:sup>\n                      M\u03c6-based immunotherapies into clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08631-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:00:31Z","timestamp":1784559631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adoptive transfer of VSIG4+ macrophages interrupts the CCL2-CCR2 inflammatory amplification loop to mitigate acetaminophen-induced acute liver injury in murine and human organoid models"],"prefix":"10.1186","volume":"24","author":[{"given":"Biao","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-6377","authenticated-orcid":false,"given":"Weifeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"8631_CR1","doi-asserted-by":"publisher","first-page":"e15739","DOI":"10.1111\/liv.15739","volume":"45","author":"P Lemmer","year":"2025","unstructured":"Lemmer P, Sowa JP, Bulut Y, Strnad P, Canbay A. Mechanisms and aetiology-dependent treatment of acute liver failure. Liver Int. 2025;45:e15739.","journal-title":"Liver Int"},{"key":"8631_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12967-024-05282-9","volume":"22","author":"A Sitbon","year":"2024","unstructured":"Sitbon A, Delmotte PR, Pistorio V, Halter S, Gallet J, Gautheron J, Monsel A. Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation. J Transl Med. 2024;22:480.","journal-title":"J Transl Med"},{"key":"8631_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.hbpd.2024.12.007","volume":"24","author":"AQ Shang","year":"2025","unstructured":"Shang AQ, Yan H, Xiang Z, Chen JQ, Jiang B, Jiang C, Ling B, Wu J, Chinese Consortium for the Study of Hepatitis E. Serum exosome-derived ALDH1A1 can greatly predict the prognosis of patients with hepatitis E virus-related acute liver failure. Hepatobiliary Pancreat Dis Int. 2025;24:170\u20136.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"8631_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S2468-1253(23)00363-1","volume":"9","author":"F Artru","year":"2024","unstructured":"Artru F, Trovato F, Morrison M, Bernal W, McPhail M. Liver transplantation for acute-on-chronic liver failure. Lancet Gastroenterol Hepatol. 2024;9:564\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8631_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12664-024-01708-w","volume":"44","author":"D Jothimani","year":"2025","unstructured":"Jothimani D, Marannan NK, Rela M. Acute liver failure and liver transplantation. Indian J Gastroenterol. 2025;44:298\u2013310.","journal-title":"Indian J Gastroenterol"},{"key":"8631_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41421-025-00831-y","volume":"11","author":"K He","year":"2025","unstructured":"He K, Zhu XJ, Shi YP, Huang WJ, Yang TH, Xi ZF, Li QG, Sun HY, Qian LJ, Chen XS, et al. Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial. Cell Discov. 2025;11:88.","journal-title":"Cell Discov"},{"key":"8631_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2020.02.031","volume":"73","author":"P Starkey Lewis","year":"2020","unstructured":"Starkey Lewis P, Campana L, Aleksieva N, Cartwright JA, Mackinnon A, O\u2019Duibhir E, Kendall T, Vermeren M, Thomson A, Gadd V, et al. Alternatively activated macrophages promote resolution of necrosis following acute liver injury. J Hepatol. 2020;73:349\u201360.","journal-title":"J Hepatol"},{"key":"8631_CR8","first-page":"242","volume":"32","author":"P Xiao","year":"2024","unstructured":"Xiao P, Han X, Huang Y, Yang J, Chen L, Cai Z, Hu N, Cui W, Huang W. Reprogramming macrophages via immune cell mobilized hydrogel microspheres for osteoarthritis treatments. Bioact Mater. 2024;32:242\u201359.","journal-title":"Bioact Mater"},{"key":"8631_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41536-025-00393-3","volume":"10","author":"ME Candela","year":"2025","unstructured":"Candela ME, Addison M, Aird R, Man TY, Cartwright JA, Ashmore-Harris C, Kilpatrick AM, Starkey Lewis PJ, Drape A, Barnett M, et al. Cryopreserved human alternatively activated macrophages promote resolution of acetaminophen-induced liver injury in mouse. NPJ Regen Med. 2025;10:5.","journal-title":"NPJ Regen Med"},{"key":"8631_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-017-01327-4","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Diao B, Guo S, Huang X, Yang C, Feng Z, Yan W, Ning Q, Zheng L, Chen Y, Wu Y. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat Commun. 2017;8:1322.","journal-title":"Nat Commun"},{"key":"8631_CR11","doi-asserted-by":"publisher","first-page":"215996","DOI":"10.1016\/j.canlet.2022.215996","volume":"553","author":"B Liu","year":"2023","unstructured":"Liu B, Cheng L, Gao H, Zhang J, Dong Y, Gao W, Yuan S, Gong T, Huang W. The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer. Cancer Lett. 2023;553:215996.","journal-title":"Cancer Lett"},{"key":"8631_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1186\/s12967-025-07239-y","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S, Li S, Wang Q, Zao X, Li X, Qi W, Cheng F, Geng Y, Zhang P, Shi X, Ye Y. New perspectives in the treatment of liver cirrhosis: targeting macrophage regulatory mechanisms. J Transl Med. 2025;23:1201.","journal-title":"J Transl Med"},{"key":"8631_CR13","doi-asserted-by":"publisher","first-page":"e70340","DOI":"10.1002\/ctm2.70340","volume":"15","author":"J Liu","year":"2025","unstructured":"Liu J, Zhang W, Chen L, Wang X, Mao X, Wu Z, Shi H, Qi H, Chen L, Huang Y, et al. VSIG4 Promotes Tumour-Associated Macrophage M2 Polarization and Immune Escape in Colorectal Cancer via Fatty Acid Oxidation Pathway. Clin Transl Med. 2025;15:e70340.","journal-title":"Clin Transl Med"},{"key":"8631_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41419-021-03806-5","volume":"12","author":"HY Cho","year":"2021","unstructured":"Cho HY, Yang YG, Jeon Y, Lee CK, Choi I, Lee SW. VSIG4(+) peritoneal macrophages induce apoptosis of double-positive thymocyte via the secretion of TNF-alpha in a CLP-induced sepsis model resulting in thymic atrophy. Cell Death Dis. 2021;12:526.","journal-title":"Cell Death Dis"},{"key":"8631_CR15","doi-asserted-by":"publisher","first-page":"e2414109","DOI":"10.1002\/advs.202414109","volume":"12","author":"Q Lu","year":"2025","unstructured":"Lu Q, Zhang Z, Ding X. Isolation Techniques of Micro\/Nano-Scaled Species for Biomedical Applications. Adv Sci (Weinh). 2025;12:e2414109.","journal-title":"Adv Sci (Weinh)"},{"key":"8631_CR16","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/hep.28682","volume":"64","author":"JC Mossanen","year":"2016","unstructured":"Mossanen JC, Krenkel O, Ergen C, Govaere O, Liepelt A, Puengel T, Heymann F, Kalthoff S, Lefebvre E, Eulberg D, et al. Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury. Hepatology. 2016;64:1667\u201382.","journal-title":"Hepatology"},{"key":"8631_CR17","doi-asserted-by":"publisher","first-page":"115318","DOI":"10.1016\/j.addr.2024.115318","volume":"209","author":"S Pozzi","year":"2024","unstructured":"Pozzi S, Satchi-Fainaro R. The role of CCL2\/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine. Adv Drug Deliv Rev. 2024;209:115318.","journal-title":"Adv Drug Deliv Rev"},{"key":"8631_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.bbrc.2019.06.045","volume":"516","author":"Y Li","year":"2019","unstructured":"Li Y, Sun JP, Wang J, Lu WH, Xie LY, Lv J, Li HX, Yang SF. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. Biochem Biophys Res Commun. 2019;516:858\u201365.","journal-title":"Biochem Biophys Res Commun"},{"key":"8631_CR19","first-page":"356","volume":"109","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ding J, Song H, Teng Y, Fang X. VSIG4 regulates macrophages polarization and alleviates inflammation through activating PI3K\/AKT and inhibiting TLR4\/NF-kappaB pathway in myocardial ischemia-reperfusion injury rats. Physiol Int. 2022;109:356\u201370.","journal-title":"Physiol Int"},{"key":"8631_CR20","doi-asserted-by":"publisher","first-page":"155586","DOI":"10.1016\/j.phymed.2024.155586","volume":"133","author":"J Lu","year":"2024","unstructured":"Lu J, Gu X, Xue C, Shi Q, Jia J, Cheng J, Zeng Y, Chu Q, Yuan X, Bao Z, Li L. Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages. Phytomedicine. 2024;133:155586.","journal-title":"Phytomedicine"},{"key":"8631_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hbpd.2024.09.010","volume":"24","author":"PP Wu","year":"2025","unstructured":"Wu PP, Shen XJ, Zheng SS. Cisplatin induces acute liver injury by triggering caspase-3\/GSDME-mediated cell pyroptosis. Hepatobiliary Pancreat Dis Int. 2025;24:177\u201387.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"8631_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","volume":"404","author":"R Maiwall","year":"2024","unstructured":"Maiwall R, Kulkarni AV, Arab JP, Piano S. Acute liver failure. Lancet. 2024;404:789\u2013802.","journal-title":"Lancet"},{"key":"8631_CR23","doi-asserted-by":"publisher","first-page":"7172","DOI":"10.1038\/s41467-021-27385-3","volume":"12","author":"Y Duan","year":"2021","unstructured":"Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, et al. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun. 2021;12:7172.","journal-title":"Nat Commun"},{"key":"8631_CR24","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.jhepr.2021.100391","volume":"4","author":"J Reissing","year":"2022","unstructured":"Reissing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Rooney M, Grosse K, et al. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep. 2022;4:100391.","journal-title":"JHEP Rep"},{"key":"8631_CR25","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-025-58999-6","volume":"16","author":"J Saris","year":"2025","unstructured":"Saris J, Li Yim AYF, Bootsma S, Lenos KJ, Franco Fernandez R, Khan HN, Verhoeff J, Poel D, Mrzlikar NM, Xiong L, et al. Peritoneal resident macrophages constitute an immunosuppressive environment in peritoneal metastasized colorectal cancer. Nat Commun. 2025;16:3669.","journal-title":"Nat Commun"},{"key":"8631_CR26","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41551-024-01287-3","volume":"8","author":"SE James","year":"2024","unstructured":"James SE, Chen S, Ng BD, Fischman JS, Jahn L, Boardman AP, Rajagopalan A, Elias HK, Massa A, Manuele D, et al. Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors. Nat Biomed Eng. 2024;8:1592\u2013614.","journal-title":"Nat Biomed Eng"},{"key":"8631_CR27","unstructured":"Vijayan Nair S. Isolation and release of circulating cells using cleavable oligonucleotide linkers in microfluidic devices: application for minimum residual disease (MRD) assessment in acute myeloid leukemia. [master\u2019s thesis]. Raleigh (NC): North Carolina State University; 2014."},{"key":"8631_CR28","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.clinre.2025.102647","volume":"49","author":"E Luce","year":"2025","unstructured":"Luce E, Messina A, Duclos-Vallee JC. Hepatic organoids as a platform for liver disease modeling and the development of novel therapies. Clin Res Hepatol Gastroenterol. 2025;49:102647.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"8631_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12967-023-04327-9","volume":"21","author":"T Li","year":"2023","unstructured":"Li T, Zeng H, Xian W, Cai H, Zhang J, Zhou S, Yang Y, Luo M, Zhu P. Maresin1 alleviates liver ischemia\/reperfusion injury by reducing liver macrophage pyroptosis. J Transl Med. 2023;21:472.","journal-title":"J Transl Med"},{"key":"8631_CR30","doi-asserted-by":"publisher","first-page":"pgaf100","DOI":"10.1093\/pnasnexus\/pgaf100","volume":"4","author":"RM Behan-Bush","year":"2025","unstructured":"Behan-Bush RM, Schrodt MV, Kilburg E, Liszewski JN, Bitterlich LM, English K, Klingelhutz AJ, Ankrum JA. Polychlorinated biphenyls induce immunometabolic switch of antiinflammatory macrophages toward an inflammatory phenotype. PNAS Nexus. 2025;4:pgaf100.","journal-title":"PNAS Nexus"},{"key":"8631_CR31","first-page":"1","volume":"45","author":"J Zhao","year":"2025","unstructured":"Zhao J, Zhi Y, Ren H, Wang J, Zhao Y. Emerging biotechnologies for engineering liver organoids. Bioact Mater. 2025;45:1\u201318.","journal-title":"Bioact Mater"},{"key":"8631_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen MMA, Coppes RP, Beghin A, De Coppi P, Gerli MFM, de Graeff N, Pan Q, Saito Y, Shi S, Zadpoor AA, van der Laan LJW. Clinical applications of human organoids. Nat Med. 2025;31:409\u201321.","journal-title":"Nat Med"},{"key":"8631_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41575-025-01116-1","volume":"23","author":"A Sljukic","year":"2026","unstructured":"Sljukic A, Green Jenkinson J, Niksic A, Prior N, Huch M. Advances in liver and pancreas organoids: how far we have come and where we go next. Nat Rev Gastroenterol Hepatol. 2026;23:44\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8631_CR34","doi-asserted-by":"publisher","first-page":"156721","DOI":"10.1016\/j.phymed.2025.156721","volume":"141","author":"Q Cao","year":"2025","unstructured":"Cao Q, Cai C, Wang C, Li L, Liu J, Zhang J, Rong M, Ren J, Han Y, Zhang J, Han X. Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids. Phytomedicine. 2025;141:156721.","journal-title":"Phytomedicine"},{"key":"8631_CR35","first-page":"550","volume":"58","author":"Z Ye","year":"2026","unstructured":"Ye Z, Yan J, Wang Y, Lin Y, Wang C, Yang Q, Ji T, Zhou E, Zheng Q, Zhong D, et al. Three-dimensional bioprinted hiHeps hepatorganoids with enhanced hepatic functions for the treatment of liver failure and promotion of liver regeneration. Bioact Mater. 2026;58:550\u201373.","journal-title":"Bioact Mater"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08631-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:00:33Z","timestamp":1784559633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08631-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8631"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08631-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The Tongji Hospital Affiliated to Tongji University Ethics Committee approved the use of human samples for this study (K-2024-055), and informed consent was obtained from all the patients. All animal experiments have been approved by the Animal Experiments Ethical Committee of Tongji Hospital Affiliated to Tongji University (2025-DW-2X-1103-L077).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"933"}}